9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer

Clinical trial NCT07314723 · RECRUITING

Trial details

NCT number: NCT07314723
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Carcinoma

Start date: 2025-08-01
Primary completion: 2027-12-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.